2020/08/06
Company:CYBERDYNE Inc.

Name ofRepresentative:

Yoshiyuki Sankai,President and CEO

Code:

7779 (Mothers Section of the Tokyo
Stock Exchange)

Contact:

Shinji Uga, Director and CFO(Tel. +81-29-869-9981)

CYBERDYNE and AI medical device startup Aillis announces business and capital tie-up~preventing infectious diseases by supporting innovative diagnosis technology that is accurate
and can be used in early stages ~CYBERDYNE Inc. [Tsukuba, Ibaraki, CEO: Yoshiyuki Sankai (the “Company”)] and Aillis Inc.[Chiyodaku, Tokyo, CEO: Sho Okiyama (“Aillis”), developed of AI medical device, made an announcement onformation of a capital tie-up (CYBERDYNE’s investment in Aillis) and a business alliance.
At the same time, Cybernics Excellence Japan Fund 1 Investment Limited Partnership (CEJ Fund)operated by CYBERDYNE’s subsidiary CEJ Capital Inc. will also make an investment to Aillis.
The Company prepared “C-Startup”, which is an ecosystem to induce innovation through providing technicaladvices, financial support and business support to start-ups with unique technologies. C-Startup was preparedto speed up the formation of the new industry of “Cybernics Industry” as an industry that will solve various
social problems through fusion of “Human” + “Cyber/Physical Space”.
Aillis is developing a device that would support diagnosis of influenza by AI image analysis of the throat.
When a person is infected with influenza, it is known that specific follicles called influenza follicles appears
in the pharynx, but only few of the experienced doctors was able to diagnosis influenza with influenza
follicles. The device developed by Aillis is developed to conduct image diagnosis using AI, so it candiagnose with better accuracy and in early stage of infection in comparison to the conventional method. It is
anticipated to be an effective counter measure towards infectious diseases.
The Company develops various Cybernics Technology such as HAL which could accumulate, analyze andAI process IoH/IoT Big Data (e.g. information related to brain-nerve system, vital system, physical system,
behavioral system, living system and environmental system) on a Cybernics Platform. By connecting thetechnology of Aillis for supporting diagnosis of infectious diseases to Cybernis Platform, two companies aimto realize an innovative measure to prevent, early detect and diagnose infectious diseases such as influenza,
making contribution to realizing a world where all people can live rich and healthy life.

CYBERDYNE Inc.
URL
https://www.cyberdyne.jp/english/
FoundedJune 2004
Share capital
26.778 billion Japanese yen (as of March 31, 2020 : non-consolidated, Japanese GAAP)
CEOPresident and CEO Yoshiyuki Sankai
Address
2-2-1 Gakuen-minami, Tsukuba, Ibaraki, Japan

The Group’s business is to realize “Society 5.0/5.1”, a future society based on the idea of TechnoPeer-Support where human and technology live together and support each other. This goal is attained
through revolutionary changes in industry and society, and The Group seeks to utilize “CybernicsTechnology” (fusion and combination of systems of human, robot and information) that handles“human” + Cyberspace” + “Physical space”, to create a “Cybernics Industry” for this transition
following the breakthroughs of the Robotics Industry and IT Industry.